Michael Dickinson, MBBS, on Bispecific Antibodies Across Lymphomas

By Blood Cancer Talks - Last Updated: December 5, 2023

In the latest episode of Blood Cancer Talks, Michael Dickinson, MBBS, DMedSc, of the Peter MacCallum Cancer Center in Melbourne, Australia, joins hosts Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD; to discuss bispecific antibodies across lymphomas.

Dr. Dickinson and the hosts circled several research articles into their conversation, including a phase I/II study of epcoritamab in relapsed or refractory diffuse large B-cell lymphoma (DLBCL); a phase II trial of mosunetuzumab in relapsed or refractory follicular lymphoma; and a phase I trial of odronextamab in relapsed or refractory B-cell non-hodgkin lymphoma (NHL).

This podcast originally appeared on Blood Cancer Talks.

What are the Risk Factors, Treatment Options for Essential Thrombocythemia?

Dr. Samer Al Hadidi Discusses CAR-T MM Data Presented at the FDA ODAC Meeting

Ayalew Tefferi, MD, on Career Development as a Clinician-Investigator

Angela Dispenzieri, MD, on Managing Newly Diagnosed AL Amyloidosis

ASH 2023 Myeloid Recap With Anand Patel, MD

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

Michael Dickinson, MBBS, on Bispecific Antibodies Across Lymphomas

Related